The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The 50-day moving average for ECSNF moved above the 200-day moving average on November 22, 2024. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Aroon Indicator entered an Uptrend today. In of 145 cases where ECSNF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Moving Average Convergence Divergence Histogram (MACD) for ECSNF turned negative on November 12, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 30 similar instances when the indicator turned negative. In of the 30 cases the stock turned lower in the days that followed. This puts the odds of success at .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ECSNF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.802) is normal, around the industry mean (3.612). P/E Ratio (0.000) is within average values for comparable stocks, (34.004). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.088). Dividend Yield (0.000) settles around the average of (0.038) among similar stocks. P/S Ratio (9.346) is also within normal values, averaging (92.747).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Industry ChemicalsSpecialty
A.I.dvisor tells us that ECSNF and NDEKY have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ECSNF and NDEKY's prices will move in lockstep.
Ticker / NAME | Correlation To ECSNF | 1D Price Change % | ||
---|---|---|---|---|
ECSNF | 100% | N/A | ||
NDEKY - ECSNF | 20% Poorly correlated | -3.64% | ||
NDEKF - ECSNF | 20% Poorly correlated | N/A | ||
DLNDY - ECSNF | 10% Poorly correlated | +10.49% | ||
CSNVY - ECSNF | 4% Poorly correlated | N/A | ||
CRDE - ECSNF | 0% Poorly correlated | N/A | ||
More |